Bloomberg the Company

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

  • Fund Type: SICAV
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: International

Carnegie Fund II - Biotechnology Sub-Fund

+ Add to Watchlist

CARBIOA:LX

34.48 EUR

As of 00:00:00 ET on 01/30/2015.

Snapshot for Carnegie Fund II - Biotechnology Sub-Fund (CARBIOA)

Year To Date: +10.12% 3-Month: +18.61% 3-Year: +43.45% 52-Week Range: 21.19 - 34.48
1-Month: +10.12% 1-Year: +51.29% 5-Year: +34.71% Beta vs CXBT: -

Mutual Fund Chart for CARBIOA

No chart data available.
  • CARBIOA:LX 34.48
  • 1M
  • 1Y
Interactive CARBIOA Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for CARBIOA

Carnegie Fund II - Biotechnology Sub-Fund is an open-end investment fund registered in Luxembourg. The Fund's objective is long-term capital growth. The Fund invests in equities of companies in the biotechnology/bioscience area including companies with activities in the areas of drug discovery & delivery, therapeutics, and enabling technologies with market cap less than 500 million.

Inception Date: 10-10-2000 Telephone: 352-40-40-30-1
Managers: ULF ARVIDSSON
Web Site: www.carnegieam.com

Fundamentals for CARBIOA

NAV (on 2015-01-30) 34.48
Assets (M) (on 2014-12-31) 28.55
Fund Leveraged N
Minimum Investment 15,000.00
Minimum Subsequent Investment -

Dividends for CARBIOA

No dividends reported

Fees & Expenses for CARBIOA

Front Load -
Back Load 0.00
Current Mgmt Fee 1.10
Redemption Fee 0.00
12b1 Fee -
Expense Ratio 1.10

Top Fund Holdings for CARBIOA

Filing Date: 12/31/2014
Name Position Value % of Total
Celgene Corp 26,400 2,490,151 8.721%
Gilead Sciences Inc 27,500 2,193,874 7.684%
Vertex Pharmaceuticals Inc 21,900 2,178,798 7.631%
Biogen Idec Inc 7,000 1,995,413 6.989%
Alexion Pharmaceuticals Inc 12,100 1,853,084 6.490%
Cempra Inc 68,000 1,341,374 4.698%
BioMarin Pharmaceutical Inc 16,800 1,274,588 4.464%
Isis Pharmaceuticals Inc 24,300 1,263,616 4.426%
Regeneron Pharmaceuticals Inc 3,600 1,237,027 4.332%
Mylan Inc/PA 26,000 1,225,889 4.293%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil